Lunai Bioworks (LNAI) Restructuring Costs (2020 - 2026)
Lunai Bioworks (LNAI) posted quarterly Restructuring Costs of $1.4 million for Q1 2026, down 66.36% year-over-year from $4.2 million in Q1 2025, and down 19.53% quarter-over-quarter from $1.8 million in Q4 2025.
Lunai Bioworks (LNAI) Restructuring Costs (2020 - 2026) Analysis & Trends
Lunai Bioworks' Restructuring Costs history runs 6 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- In Q1 2026, Restructuring Costs fell 66.36% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $9.6 million (down 25.04% YoY), while the FY2025 annual figure was $17.9 million, down 27.19% from the prior year.
- Restructuring Costs for Q1 2026 stood at $1.4 million, down from $1.8 million in the prior quarter.
- The five-year high for Restructuring Costs was $4.4 million in Q4 2024, with the low at $1.4 million in Q1 2026.
- The 4-year median for Restructuring Costs is $4.0 million (2025), against an average of $3.2 million.
- The sharpest annual moves came in 2022 and 2026: Restructuring Costs soared 32.11% in 2022, then tumbled 66.36% in 2026.
- Lunai Bioworks' Restructuring Costs stood at $4.0 million in 2022, then rose by 7.9% to $4.4 million in 2024, then plunged by 59.43% to $1.8 million in 2025, then dropped by 19.53% to $1.4 million in 2026.
- Business Quant data shows LNAI's Restructuring Costs at $1.4 million in Q1 2026, $1.8 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | 1.77 Mn |
| Sep 30, 2025 | 2.41 Mn |
| Jun 30, 2025 | 4.00 Mn |
| Mar 31, 2025 | 4.22 Mn |
| Dec 31, 2024 | 4.35 Mn |
| Mar 31, 2022 | 4.03 Mn |
| Dec 31, 2021 | 193,137.00 |
| Sep 30, 2021 | 49,192.00 |
| Jun 30, 2021 | -9.04 Mn |
| Mar 31, 2021 | 3.05 Mn |
| Dec 31, 2020 | 3.31 Mn |
| Sep 30, 2020 | 2.86 Mn |